These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 18021882

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. NTproBNP-guided drug treatment for chronic heart failure: design and methods in the "BATTLESCARRED" trial.
    Lainchbury JG, Troughton RW, Frampton CM, Yandle TG, Hamid A, Nicholls MG, Richards AM.
    Eur J Heart Fail; 2006 Aug; 8(5):532-8. PubMed ID: 16829189
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Therapy optimization of heart failure through the evaluation of the plasma concentration variation of B-type natriuretic peptide].
    Coppola A, De Paola G, Suppa M, Maggi B, Giancaspro G, Colzi M, Scarpellini MG, Lacenere L, Gerratana G, Aguglia F.
    Clin Ter; 2006 Aug; 157(6):495-505. PubMed ID: 17228848
    [Abstract] [Full Text] [Related]

  • 6. [Natriuretic peptides in patients with heart failure].
    Horii M, Saito Y.
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():84-7. PubMed ID: 15506343
    [No Abstract] [Full Text] [Related]

  • 7. Brain natriuretic peptide-guided management of chronic heart failure: first do no harm.
    Richards AM.
    Eur J Heart Fail; 2013 Aug; 15(8):832-4. PubMed ID: 23821462
    [No Abstract] [Full Text] [Related]

  • 8. Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure.
    McMurray JJ, Pitt B, Latini R, Maggioni AP, Solomon SD, Keefe DL, Ford J, Verma A, Lewsey J, Aliskiren Observation of Heart Failure Treatment (ALOFT) Investigators.
    Circ Heart Fail; 2008 May; 1(1):17-24. PubMed ID: 19808266
    [Abstract] [Full Text] [Related]

  • 9. Effects of aspirin and clopidogrel on plasma brain natriuretic peptide in patients with heart failure receiving ACE inhibitors.
    Meune C, Wahbi K, Fulla Y, Cohen-Solal A, Duboc D, Mahé I, Simoneau G, Bergmann JF, Weber S, Mouly S.
    Eur J Heart Fail; 2007 Feb; 9(2):197-201. PubMed ID: 16914369
    [Abstract] [Full Text] [Related]

  • 10. Paediatric heart failure trials...and tribulations.
    Shaddy RE.
    Cardiol Young; 2007 Aug; 17(4):354-5. PubMed ID: 17572938
    [No Abstract] [Full Text] [Related]

  • 11. New therapies for heart failure.
    Riggs JM.
    RN; 2004 Mar; 67(3):28-32; quiz 33. PubMed ID: 15065491
    [No Abstract] [Full Text] [Related]

  • 12. The 2002/3 Canadian Cardiovascular Society consensus guideline update for the diagnosis and management of heart failure.
    Liu P, Arnold JM, Belenkie I, Demers C, Dorian P, Gianetti N, Haddad H, Howlett J, Ignazewski A, Jong P, McKelvie R, Moe G, Parker JD, Rao V, Rouleau JL, Teo K, Tsuyuki R, White M, Huckel V, Issac D, Johnstone D, LeBlanc MH, Lee H, Newton G, Niznick J, Ross H, Roth S, Roy D, Smith S, Sussex B, Yusuf S, Canadian Cardiovascular Society.
    Can J Cardiol; 2003 Mar 31; 19(4):347-56. PubMed ID: 12704478
    [No Abstract] [Full Text] [Related]

  • 13. Can BNP-guided therapy improve health-related quality of life, and do responders to BNP-guided heart failure treatment have improved health-related quality of life? Results from the UPSTEP study.
    Karlström P, Johansson P, Dahlström U, Boman K, Alehagen U.
    BMC Cardiovasc Disord; 2016 Feb 13; 16():39. PubMed ID: 26905220
    [Abstract] [Full Text] [Related]

  • 14. [Drug therapy of heart failure. Don't wait until the legs swell].
    MMW Fortschr Med; 2002 Jul 26; 144(29-30):4-5. PubMed ID: 12219611
    [No Abstract] [Full Text] [Related]

  • 15. A mechanistic interaction remains to be determined for elevated NTproBNP in heart failure patients receiving both an ACE inhibitor and aspirin.
    McLachlan CS, Zhang Z, Mossop P.
    J Card Fail; 2007 Feb 26; 13(1):75-6. PubMed ID: 17339006
    [No Abstract] [Full Text] [Related]

  • 16. [Is it always necessary to use triple combination in the treatment of patients with chronic cardiac failure? Choice of the third neurohormonal blocker].
    Belenkov IuN, Mareev VIu, Skvortsov AA.
    Ter Arkh; 2008 Feb 26; 80(9):5-12. PubMed ID: 19555028
    [No Abstract] [Full Text] [Related]

  • 17. [Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations].
    Latini R, Masson S.
    Ital Heart J Suppl; 2000 Aug 26; 1(8):1068-9. PubMed ID: 10993019
    [No Abstract] [Full Text] [Related]

  • 18. B-type natriuretic peptide predicts benefit from a home-based nurse care in chronic heart failure.
    Moertl D, Berger R, Hammer A, Huelsmann M, Hutuleac R, Pacher R.
    J Card Fail; 2009 Apr 26; 15(3):233-40. PubMed ID: 19327625
    [Abstract] [Full Text] [Related]

  • 19. Angiotensin-converting enzyme inhibitors or beta-blockers in heart failure: does it matter who goes first?
    Fang JC.
    Circulation; 2005 Oct 18; 112(16):2380-2. PubMed ID: 16230494
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.